Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease [Phase 2]

View source ↗

Summary

This clinical trial update indicates that SC0062 is being investigated in a Phase 2 study for chronic kidney disease, including diabetic kidney disease and IgA …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Iga Nephropathy

Drugs mentioned

• SC0062

Snippet

Sponsor: Biocity Biopharmaceutics Co., Ltd. | Conditions: Diabetic Kidney Disease, IgA Nephropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING